These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11094920)

  • 61. Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury.
    Mathias CJ; Luckitt J; Desai P; Baker H; el Masri W; Frankel HL
    J Rehabil Res Dev; 1989; 26(4):9-16. PubMed ID: 2600869
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud).
    Emre M; Leslie GC; Muir C; Part NJ; Pokorny R; Roberts RC
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1355-9. PubMed ID: 7964811
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tizanidine (Zanaflex): a muscle relaxant that may prolong the QT interval by blocking IKr.
    Kaddar N; Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):102-9. PubMed ID: 21317414
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduction of centrally-stimulated gastric acid secretion by tizanidine, a new imidazoline derivative, in anesthetized rats.
    Maeda-Hagiwara M; Watanabe H; Kanaoka R; Watanabe K
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):321-7. PubMed ID: 3933446
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies.
    Knutsson E
    Adv Neurol; 1983; 39():1013-34. PubMed ID: 6229155
    [No Abstract]   [Full Text] [Related]  

  • 66. [Current data on bipolar disorders, epilepsy and spasticity. 4. Neuro-Forum, Dresden].
    Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Aktuelles):1-12. PubMed ID: 10368778
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of antispastic drugs on motor reflexes and voluntary muscle contraction in incomplete spinal cord injury.
    Chu VW; Hornby TG; Schmit BD
    Arch Phys Med Rehabil; 2014 Apr; 95(4):622-32. PubMed ID: 24269485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The use of tizanidine in combined treatment of arm poststroke spasticity].
    Khasanova DR; Agafonova NV; Starostina GKh
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):57-60. PubMed ID: 25591637
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.
    Granfors MT; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Dec; 76(6):598-606. PubMed ID: 15592331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tizanidine in cranial dystonia.
    Lang AE; Riley DE
    Clin Neuropharmacol; 1992 Apr; 15(2):142-7. PubMed ID: 1591739
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Substantia nigra and entopeduncular nucleus: supraspinal sites of the muscle relaxant action of tizanidine.
    Turski L; Schwarz M; Klockgether T; Sontag KH
    Brain Res; 1986 Aug; 379(2):367-71. PubMed ID: 3742228
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Tizanidine in the treatment of acute withdrawal symptoms in heroin dependent patients].
    Sós I; Kiss N; Csorba J; Gerevich J
    Orv Hetil; 2000 Apr; 141(15):783-6. PubMed ID: 10808729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antispasticity medications.
    Nance PW; Young RR
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):337-55, viii. PubMed ID: 10370935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of tizanidine administration on exteroceptive suppression of the temporalis muscle in patients with chronic tension-type headache.
    Nakashima K; Tumura R; Wang Y; Shimoda M; Sakuma K; Takahashi K
    Headache; 1994 Sep; 34(8):455-7. PubMed ID: 7960728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of clonidine and a new related imidazoline derivative (tizanidine) on rat gastric mucosa.
    Maeda-Hagiwara M; Watanabe H; Kanaoka R; Watanabe K
    Pharmacology; 1986; 32(2):109-13. PubMed ID: 3952131
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A new skeletal muscle relaxant (DS 103-282) compared to diazepam in the treatment of muscle spasm of local origin.
    Hennies OL
    J Int Med Res; 1981; 9(1):62-8. PubMed ID: 6451461
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tizanidine and spasticity.
    Landau WM
    Neurology; 1995 Dec; 45(12):2295-6. PubMed ID: 8848215
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparison between the therapeutic effects of robotic-assisted locomotor training and an anti-spastic medication on spasticity.
    Mirbagheri MM
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():4675-8. PubMed ID: 26737337
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Centrally acting skeletal muscle relaxants and associated drugs.
    Waldman HJ
    J Pain Symptom Manage; 1994 Oct; 9(7):434-41. PubMed ID: 7822882
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of the myotonolytic activity of tizanidine, eperisone and afloqualone in mouse and rabbit.
    Coward DM; White TG
    J Int Med Res; 1989; 17(4):358-62. PubMed ID: 2792555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.